4//SEC Filing
Holmes Scott A 4
Accession 0001114220-17-000041
CIK 0001114220other
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 4:11 PM ET
Size
5.0 KB
Accession
0001114220-17-000041
Insider Transaction Report
Form 4
Holmes Scott A
Chief Financial Officer
Transactions
- Sale
Common Stock
2017-10-30$6.03/sh−2,582$15,569→ 139,700 total
Footnotes (2)
- [F1]Sale of a total of 2,582 shares of common stock was made in order to satisfy Mr. Holmes' income tax withholding obligation upon the vesting of 8,229 shares of restricted stock on October 27, 2017. Mr. Holmes had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 82,392 shares of restricted stock.
Documents
Issuer
KERYX BIOPHARMACEUTICALS INC
CIK 0001114220
Entity typeother
Related Parties
1- filerCIK 0001537670
Filing Metadata
- Form type
- 4
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 4:11 PM ET
- Size
- 5.0 KB